Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS.

Multiple intravenous administrations of human umbilical cord blood cells benefit in a mouse model of ALS.

A promising therapeutic strategy for amyotrophic lateral sclerosis (ALS) is the use of cell-based therapies that can protect motor neurons and thereby retard disease progression. We recently showed that a single large dose (25 × 10⁶ cells) of mononuclear cells from human umbilical cord blood (MNC hU...

Full description

Bibliographic Details
Main Authors: Svitlana Garbuzova-Davis, Maria C O Rodrigues, Santhia Mirtyl, Shanna Turner, Shazia Mitha, Jasmine Sodhi, Subatha Suthakaran, David J Eve, Cyndy D Sanberg, Nicole Kuzmin-Nichols, Paul R Sanberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3272008?pdf=render

Internet

http://europepmc.org/articles/PMC3272008?pdf=render

Similar Items